| Antimicrobial Resistance Phenotype | ||||
|---|---|---|---|---|
| Epidemiological feature |
Non-Multi Resistant (n: 433) |
Multi-Resistant (n: 335) |
OR (CI 95%) |
Multi-Variate Analysis (p) |
| Female patients (F:M) | 323 (2.9:1) | 207 (1.6:1) | 0,64 (0.45-0.92) | 0.019 |
| Diabetes mellitus (%) | 25 (5.8) | 68 (20.3) | 4.56 (2.95-7.05) | <0.0001 |
| Recurrent urinary tract infections (%) | 37 (8.5) | 108 (32.2) | 2.94 (1.94-4.45) | <0.0001 |
| Hospitalization during the last year (%) | 53 (12.2) | 123 (36.7) | 2.37 (1.23-4.57) | 0.0076 |
| Chronic renal failure (%) | 17 (3.9) | 63 (18.8) | 1.52 (0.52-4.38) | 0.5987 |
| Autoimmune disease (%) | 8 (1.8) | 25 (7.5) | 0.25 (0.06-1.05) | 0.0779 |
| Exposure to antimicrobials in the last 3 months (%) | 73 (16.9) | 132 (39.4) | 1.23 (0.64-2.37) | 0.4671 |
| Exposure to β-lactams in the last 3 months (%) | 36 (8.3) | 98 (29.3) | 2.68 (1.36-5.26) | 0.0027 |
| Exposure to quinolones in the last 3 months (%) | 52 (12) | 93 (27.8) | 1.05 (0.72-1.51) | 0.8477 |